Oldip HCT Tablet 5/20/12.5 mg

Adult dose

This medication should be taken once daily, with or without food, along with water. It is recommended to take it at the same time every day (e.g., in the morning). The maximum dose for amlodipine/olmesartan medoxomil/hydrochlorothiazide is 10/40/25 mg. The maximum antihypertensive effect occurs within 2 weeks of administration, so dosage adjustments should be made at intervals of more than 2 weeks. The recommended dosage is 5/20/12.5 mg, 5/40 mg.

Child dose

The safety and efficacy of this medication in pediatric patients under the age of 18 have not been established, and its administration is not recommended.

This medication should not be used during the second and third trimesters of pregnancy as it can cause serious harm to the fetus and newborn. Patients with an allergy to this medication or any of its components, or those with specific heart, kidney, or liver diseases should not take it. Patients with excessively low blood pressure or unstable conditions after acute myocardial infarction may also be at risk when taking this medication. Patients with low blood volume or electrolyte imbalances should be particularly cautious when starting this medication, and any symptoms of hypotension should be treated immediately. Patients with impaired kidney function or kidney transplant recipients should have their kidney function regularly monitored while taking this medication. Patients with severely impaired liver function should avoid taking this medication. As this medication lowers blood pressure, caution is needed while driving or operating machinery, as dizziness may occur. Electrolyte levels in the blood should be regularly monitored during treatment with this medication to ensure there are no abnormalities. Particularly, potassium levels may become too high or too low, so caution is required when taking potassium supplements or medications that affect potassium excretion. This medication may interact with other blood pressure medications, analgesics, and lithium preparations, so if you are taking other medications, consult a physician or pharmacist. This medication is not recommended for breastfeeding women, and it is advisable to avoid taking it while breastfeeding. For patients under 18 years of age, its safety and efficacy have not been established, so its use should be avoided. Elderly patients may be more sensitive to this medication, so dosage adjustments and careful monitoring are necessary. In cases of overdose, symptoms such as hypotension and heart rhythm abnormalities may occur; immediate medical assistance should be sought. This medication should be stored away from moisture and heat, and kept out of the reach of children. If any abnormal symptoms or side effects arise during use, it is essential to consult a healthcare professional immediately.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, cough with fever and breathing difficulties, yellowing of skin or eyes (jaundice), severe lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Headache
• dizziness
• peripheral edema
• urinary tract infection
• nasopharyngitis
• upper respiratory tract infection
• sialadenitis
• leukopenia
• thrombocytopenia
• bone marrow suppression

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, avoid very hot or very cold places, and store it at a temperature between 1 and 30 degrees Celsius, which is room temperature.

Appearance

White and orange round film-coated tablets

Package unit

28 tablets (14 tablets/PTPX2)/carton